Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 May 2021 | Story Ilze Bakkes

The COVID-19 outbreak in South Africa and the subsequent national lockdown severely impacted the usual physical open day mass-marketing tactic. At the same time, it provided an opportunity for the Department of Student Recruitment Services (SRS) to be super creative and agile in promoting the UFS offerings to the target audiences. 

Once a year, the UFS invites prospective learners and parents to visit our campuses for a taste of campus life. But for many interested students, especially those living remotely or abroad, a site visit is not always practical. Furthermore, the 2021 open days on the Bloemfontein and Qwaqwa Campuses were again cancelled due to the COVID-19 pandemic. The 2020 Virtual Open Day proved that breaking from the traditional recruitment tactics and moving into the virtual domain was not only bold and innovative, but also offered more engagement and communication opportunities with prospective students. Building on the insights and success of COVID-19 response engagements, the Department of Student Recruitment Services has once again developed an immersive virtual experience for prospective students. 

Ilze Bakkes, Chief Officer: Integrated Marketing and Innovation from the Department of Student Recruitment Services, says: “We listened to the needs and wants of our prospective students and staff. Therefore, the 2021 Virtual Expo will have undergraduate, postgraduate, and international student recruitment foci, offering more and relevant information in a visual, multi-layered, and digital way.” Information is presented through videos, photos, downloadable PDF brochures, and links to marketing material and the online application platform. 

A challenge during the physical open day is the lack of time to engage with faculties or that not all the information could be obtained. The Virtual Expo is live now click here and can be visited until 30 September 2021, when applications to study undergraduate and postgraduate programmes in 2022 close. The Virtual Expo offers a professional, easy-to-navigate and hassle-free digital experience of the academic, social, and cultural life at the UFS on all three campuses – in the convenience of the visitor’s own space and time. Subtexts for videos enable differently abled visitors to enjoy the content, and data-sensitive visitors can download the PDF versions of videos. 

Applications to study in 2022 are already open. To apply, click here (link to online application). For important closing dates, download the UFS Undergraduate Prospectus

For information on the Virtual Expo, contact Ilze Bakkes at +27 51 401 9028 or bakkese@ufs.ac.za.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept